HS135, A Novel Activin and GDF Trap, is Highly Efficacious in Models of Group 1 and Group 2 Pulmonary Hypertension (PH)

Basic mechanism in pulmonary hypertension

Chair(s): Andrea Olschewski, Frances S. de Man

Session type: Poster session

Gauthier Schang

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

The role of BMP9-induced Sema3G in pulmonary vascular stability

Sarah Mirza

Poster

Abstract

Targeting ATP Citrate Lyase to mitigate Vascular Remodeling Pathogenesis.

Yann Grobs

Poster

Abstract

Selective inhibition of Histone deacetylases reverses vascular remodeling and improves right ventricle function in pulmonary hypertension

Konda Babu Kurakula

Poster

Abstract

The role of miR-146a in the pathophysiology of pulmonary arterial hypertension

Joana Gomes

Abstract

Role of Bone Morphogenetic Protein-9 in the development of Hepatopulmonary Syndrome

Fabien Robert

Poster

Abstract

Remodeling of pulmonary arterial (PA) endothelial basement membrane (BM) triggers smooth muscle cell (SMC) hyperplasia in pulmonary hypertension due to left heart disease (PH-LHD)

Mariya Kucherenko

Abstract

Alpha?B crystallin regulates apoptosis in idiopathic pulmonary arterial hypertensive smooth muscle cells

Dongqi Xing

Abstract

Proteomic profiling of pulmonary hypertension associated with respiratory disease

Adelaida Bosacoma

Poster

Abstract

Empagliflozin improves mitochondrial biogenesis and ameliorates vascular remodeling in experimental pulmonary arterial hypertension

Erik Duijvelaar

Poster

Abstract

The matrikine Ac-PGP mediates the pathogenesis of pulmonary hypertension

Xin Xu

Abstract

Cannabidiol alleviates cardiac fibrosis probably through inhibiting endothelial-to-mesenchymal transition in rat model of pulmonary hypertension

Anna Krzyzewska

Abstract

Role of histone acetyltransferases P300/CBP in pulmonary arterial hypertension and right heart failure

Alice Bourgeois

Poster

Abstract

HS135, A Novel Activin and GDF Trap, is Highly Efficacious in Models of Group 1 and Group 2 Pulmonary Hypertension (PH)

Gauthier Schang

Poster

Abstract

Size does matter: a simple swine model of chronic pulmonary hypertension

Liliana Moreira-costa

Poster

Abstract

Synthesis of CeO2@BSA Nanoclusters for Inhibition of Pulmonary microvascular endothelial Cell Dysfunction and Improvement of Rat Vascular Reconstitution

Ping Yuan

Poster

Abstract

SMAD5 as a novel gene for familial pulmonary arterial hypertension

Ding Cao

Poster

Abstract

The Fibronectin-Binding Integrins System as a Contributor to PAH Pathogenesis

Sarah-eve Lemay

Poster

Abstract

Targeting DHPS-mediated hypusination of eIF5A improves vascular remodeling in PAH

Sarah-eve Lemay

Poster

Abstract

Osteopontin in experimental right ventricular remodeling

Argen Mamazhakypov

Poster

Abstract

Differential responses of pulmonary vascular cells from PAH patients and controls to TNF? and the effect of the BET inhibitor JQ1.

Ian M. Adcock

Poster

Abstract

The ERS International Congress 2023, Milan

#{title}